With an at least $60 billion total addressable market, the liquid biopsy sector offers abundant opportunity for multiple companies to swim to the top. The six largest companies in the pool have just ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

Dynamic Biopsy non-invasively analyses dynamic biological processes within a specific organ or tissue to assess its health ...

Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek™ platform for immunotherapy response in metastatic ...

Guardant Health has an expanding pipeline that could significantly boost its future market potential. Check out my ...

Anti-neurofilament L antibodies play a crucial role in detecting and monitoring neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis ...

Government and private funding for genomic research is the key factor driving market revenue growth. According to the Alzheimer’s Disease International, As of June 2024, it is anticipated that more ...

RBC Capital initiated coverage of Exact Sciences (EXAS) with a Sector Perform rating and $52 price target while launching ...

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...